The FDA outlines its ibogaine trial vision, Compass Pathways reveals pricing and slow rollout plans, and early healthcare leaders weigh in—here’s what DMV readers need to know.
New Ohio regulations restrict high-potency cannabis products, impacting dispensaries and consumers. Here’s what changed—and why the DMV should pay attention.
Psychedelic Alpha flagged a busy “Psychedelics Week” in DC with multiple meetings. Here’s what that activity could signal for policy, access, and the DMV community.
Athletes report flow, less pain, and sharper focus on mushrooms, LSD, and ketamine—but the science is thin. Here’s what research suggests, key risks, and DMV-specific guidance.
New research from 2025 looked at how heavy cannabis use impacts cognitive function. This article unpacks the findings and provides context for DMV cannabis consumers.
Wan't to get Cannabis News and Blog Updates from Bud Lords Weed Delivery in Washington DC? Sign up and Become a member to get updates on new blogs and washington dc weed events.